Model N investing in India to support Asia Pacific growth
US-based Model N is to invest up to Rs 100 crore ($21m) in its Indian operations to meet growing demand for its revenue management services.
Archives for June 29, 2010
Biomarkers in demand but CROs cautious, study
Demand for biomarker analysis is strong, but the pace of technological change is causing an investment headache for CROs according to a new report by Industry Standard Research (ISR).
NeoStem’s cGMP approval finds favour with investors
Suzhou Erye, a subsidiary of NeoStem Pharmaceutical, has passed inspection by the Chinese Food and Drug Administration (SFDA) meaning the company's new manufacturing facility will go ahead with the manufacture of penicillin and cephalosporin powder for...
Sanofi to set up new facility in Saudi Arabia
Sanofi-Aventis will build a new manufacturing plant in King Abdullah Economic City (KAEC) in Saudi Arabia through an agreement with the Emaar development company (ECC).
Icon opens China lab
CRO Icon has opened a 3,000 sq ft central laboratory in Tianjin, China in partnership with Fountain Medical Development (FMD).
Max Neeman and QED boost CDISC offerings
Indian CROs Max Neeman International and QED Pharmaceutical Services have both added US Food and Drug Administration’s (FDA) CDISC compliance to their data management offering this month.
Alembic to demerge pharma business
India’s oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board approved the demerging of its main pharmaceutical business into a separate subsidiary company, Alembic Pharma.
Appointments at DSM, Codexis, USP and MonoSol Rx – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma space, including appointments at DSM, Codexis, USP and MonoSol Rx.
Colorcon adds formulation labs in Brazil
Colorcon has added processing and formulation development capacity at its technical service laboratory in Cotia near Sao Paulo, Brazil.